TrialDiabetes, obesity & metabolism2019

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial.

Weiqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.